Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-12 Sale | 2024-02-13 5:05 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 1,148 | $67.77 | $77,796 | 92,453 (Direct) | View |
| 2024-01-29 Sale | 2024-01-31 4:36 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 906 | $64.14 | $58,109 | 93,601 (Direct) | View |
| 2024-01-22 Sale | 2024-01-23 6:15 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 3,413 | $65 | $221,831 | 94,507 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 4:37 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 2,235 | $66.81 | $149,317 | 132,453 (Direct) | View |
| 2023-12-01 Sale | 2023-12-05 7:29 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 110,000 | $60.81 | $6,689,303 | 248,907 (Direct) | View |
| 2023-05-03 Sale | 2023-05-04 4:40 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $82.71 | $413,550 | 358,495 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 4:50 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $74.05 | $370,250 | 363,495 (Direct) | View |
| 2023-03-03 Sale | 2023-03-07 4:53 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $63.84 | $319,200 | 368,495 (Direct) | View |
| 2023-02-03 Sale | 2023-02-06 5:35 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $55.85 | $279,250 | 365,432 (Direct) | View |
| 2023-01-03 Sale | 2023-01-05 8:00 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $50.7 | $253,500 | 345,407 (Direct) | View |
| 2022-12-05 Sale | 2022-12-07 08:30 am | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $50.38 | $251,900 | 350,407 (Direct) | View |
| 2022-11-03 Sale | 2022-11-07 4:19 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $58.54 | $292,700 | 355,407 (Direct) | View |
| 2022-10-03 Sale | 2022-10-05 5:12 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $66.69 | $333,450 | 360,407 (Direct) | View |
| 2022-09-06 Sale | 2022-09-07 4:37 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $60.38 | $301,900 | 365,407 (Direct) | View |
| 2022-08-15 Sale | 2022-08-16 5:04 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $69 | $862,500 | 370,407 (Direct) | View |
| 2022-08-11 Sale | 2022-08-12 5:01 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $67 | $837,500 | 382,907 (Direct) | View |
| 2022-08-08 Sale | 2022-08-09 5:22 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $65 | $812,500 | 395,407 (Direct) | View |
| 2022-08-03 Sale | 2022-08-04 6:40 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $56.43 | $282,150 | 407,907 (Direct) | View |
| 2022-07-11 Sale | 2022-07-12 5:55 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $48.42 | $242,100 | 414,782 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-16 Option Award | 2024-01-17 4:37 pm | N/A 2034-01-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 34,533 | $66.3 | 132,453 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-17 4:37 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 23,748 | $0 | 132,453 (Direct) | View |
| 2023-12-01 Exercise | 2023-12-05 7:29 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 110,000 | $0 | 248,907 (Direct) | View |
| 2023-12-01 Exercise | 2023-12-05 7:29 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 110,000 | $15.09 | 248,907 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-04 4:40 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 358,495 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-04 4:40 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 358,495 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 4:50 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 363,495 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 4:50 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 363,495 (Direct) | View |
| 2023-03-03 Exercise | 2023-03-07 4:53 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 368,495 (Direct) | View |
| 2023-03-03 Exercise | 2023-03-07 4:53 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 368,495 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 06:36 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 1,041 | $58.5 | 90,018 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-22 06:36 am | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 23,909 | $0 | 90,018 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 5:03 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 782 | $51.21 | 67,150 (Direct) | View |
| 2023-02-03 Exercise | 2023-02-06 5:35 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 365,432 (Direct) | View |
| 2023-02-03 Exercise | 2023-02-06 5:35 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 365,432 (Direct) | View |
| 2023-01-27 Tax Withholding | 2023-01-30 5:07 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 551 | $52.77 | 67,932 (Direct) | View |
| 2023-01-20 Tax Withholding | 2023-01-24 5:32 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 1,912 | $52.05 | 68,483 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 7:44 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 27,488 | $0 | 113,578 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 7:44 pm | N/A 2033-01-11 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 43,183 | $52.66 | 113,578 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-05 8:00 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 345,407 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-05 8:00 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 345,407 (Direct) | View |
| 2022-12-05 Exercise | 2022-12-07 08:30 am | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 350,407 (Direct) | View |
| 2022-12-05 Exercise | 2022-12-07 08:30 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 350,407 (Direct) | View |
| 2022-11-03 Exercise | 2022-11-07 4:19 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 355,407 (Direct) | View |
| 2022-11-03 Exercise | 2022-11-07 4:19 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 355,407 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-05 5:12 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 360,407 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-05 5:12 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 360,407 (Direct) | View |
| 2022-09-06 Exercise | 2022-09-07 4:37 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 365,407 (Direct) | View |
| 2022-09-06 Exercise | 2022-09-07 4:37 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 365,407 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-16 5:04 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $0 | 370,407 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-16 5:04 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $15.09 | 370,407 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 5:01 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $0 | 382,907 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 5:01 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $15.09 | 382,907 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-09 5:22 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $0 | 395,407 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-09 5:22 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $15.09 | 395,407 (Direct) | View |
| 2022-08-03 Exercise | 2022-08-04 6:40 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 407,907 (Direct) | View |
| 2022-08-03 Exercise | 2022-08-04 6:40 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 407,907 (Direct) | View |
| 2022-04-21 Other | 2022-07-12 5:55 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 13,125 | $0 | 414,782 (Direct) | View |
| 2022-07-11 Exercise | 2022-07-12 5:55 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 414,782 (Direct) | View |
| 2022-07-11 Exercise | 2022-07-12 5:55 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 414,782 (Direct) | View |
| 2022-02-10 Tax Withholding | 2022-02-14 4:34 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 895 | $47.12 | 44,013 (Direct) | View |
| 2022-01-28 Tax Withholding | 2022-02-01 6:01 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 800 | $38.59 | 44,908 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 4:55 pm | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 63,002 | $0 | 82,659 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-11 4:10 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 688 | $47.72 | 18,865 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:44 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 65,625 | $0 | 75,803 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:02 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. See Remarks | 65,625 | $0 | 65,625 (Direct) | View |